[Experiences with a new antiallergic drug in 310 cases of pollen allergy].
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006979:Hyperthermia, Induced; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D014309:Tripelennamine / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants; D014309:Tripelennamine
ANALEPTICS/therapeutic use; HAY FEVER/therapy; TRIPELENNAMINE/therapeutic use
Erfahrungen mit einem neuartigen Antiallergikum bei 310 Pollenallergikern.